Hongrui Niu

Effect and mechanism of ginsenoside Rg3 on postoperative life span of patients with non-small cell lung cancer

Ping Lu, Wei Su, Zhanhui Miao et al. · Chinese Journal of Integrative Medicine · 2008 · 122 citations

Medicine, Oncology, Pharmacology +9

Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study

Yuankai Shi, Xingsheng Hu, Shucai Zhang et al. · The Lancet Respiratory Medicine · 2021 · 121 citations

Medicine, Molecular Genetics, Oncology +17

Sintilimab versus docetaxel as second‐line treatment in advanced or metastatic squamous non‐small‐cell lung cancer: an open‐label, randomized controlled phase 3 trial (ORIENT‐3)

Yuankai Shi, Lin Wu, Xinmin Yu et al. · Cancer Communications · 2022 · 58 citations · Full text

Medicine, Oncology, Pharmacotherapy +10

miR-218 is downregulated and directly targets SH3GL1 in childhood medulloblastoma

Jipeng Shi, Liuzhong Yang, Tuanjie Wang et al. · Molecular Medicine Reports · 2013 · 28 citations · Full text

Medicine, Cancer Biology, Oncology +17

Central nervous system efficacy of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small cell lung cancer: a pooled analysis from two phase 2 studies

Xingsheng Hu, Shucai Zhang, Zhiyong Ma et al. · BMC Medicine · 2023 · 21 citations · Full text

Medicine, Oncology, Pharmacology +16